Ugandan biotech unveils Sickle cell cure millions can afford.

Simple item page
dc.contributor.authorObserver
dc.date.accessioned2026-04-15T10:05:16Z
dc.date.available2026-04-15T10:05:16Z
dc.date.issued2026-02-04
dc.descriptionNews article
dc.description.abstractFor Patients with sickle cell disease, particularly in sub-saharan Africa where the condition is most common, that promise has long left out of research.
dc.identifier.citationObserver. (2026). Ugandan biotech unveils Sickle cell cure millions can afford. Observer.
dc.identifier.urihttps://bdears.busitema.ac.ug/handle/123456789/1335
dc.language.isoen
dc.publisherObserver
dc.titleUgandan biotech unveils Sickle cell cure millions can afford.
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Daily Monitor-10-04-2026.pdf
Size:
2.93 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Faculty of Health Sciences